Oftalmoloxía
Servicio
Alfredo
García Layana
Publicacións nas que colabora con Alfredo García Layana (23)
2024
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
2023
-
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Ophthalmology, Vol. 130, Núm. 6, pp. 588-597
-
Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea
Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626
2022
-
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes
Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324
-
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
The Lancet, Vol. 399, Núm. 10326, pp. 729-740
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
The Lancet, Vol. 399, Núm. 10326, pp. 741-755
-
Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry
Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053
-
The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world
Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531
2021
-
A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration
Nutrients, Vol. 13, Núm. 4
-
Recommendations for ophthalmologic practice during the easing of COVID-19 control measures
Acta Ophthalmologica, Vol. 99, Núm. 7, pp. e973-e983
2020
-
Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829
2018
-
Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration
Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212
-
Clinical decision-making when treating diabetic macular edema patients with dexamethasone intravitreal implants
Ophthalmologica, Vol. 240, Núm. 2, pp. 61-72
2017
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
-
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Drugs and Aging, Vol. 32, Núm. 10, pp. 797-807
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
Do nutritional supplements have a role in age macular degeneration prevention?
Journal of Ophthalmology, Vol. 2014
2013
-
Smoking and age-related macular degeneration: Review and update
Journal of Ophthalmology, Vol. 2013
2011
-
Myopic choroidal neovascularization
Ophthalmology